Seeing Is Believing
Currently out of the existing stock ratings of Jim Molloy, 46 are a BUY (93.88%), 2 are a SELL (4.08%), 1 are a HOLD (2.04%).
Analyst Jim Molloy, currently employed at ALLIANCE GLOBAL PARTNERS, carries an average stock price target met ratio of 46.15% that have a potential upside of 22.8% achieved within 181 days.
Jim Molloy’s has documented 93 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TNXP, Tonix Pharmaceuticals Holding Corp at 01-Aug-2023.
Analyst best performing recommendations are on TNXP (TONIX PHARMACEUTICALS HOLDING CORP).
The best stock recommendation documented was for TNXP (TONIX PHARMACEUTICALS HOLDING CORP) at 1/12/2023. The price target of $6.5 was fulfilled within 6 days with a profit of $1 (13.33%) receiving and performance score of 22.22.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$19
$19
2 years 17 days ago
(26-Sep-2023)
10/13 (76.92%)
$0.42 (2.26%)
63
Hold
$19
$12
2 years 17 days ago
(26-Sep-2023)
5/8 (62.5%)
$0.42 (2.26%)
137
Hold
$19
$13
2 years 17 days ago
(26-Sep-2023)
12/25 (48%)
$0.42 (2.26%)
39
Hold
$19
$20
2 years 17 days ago
(26-Sep-2023)
3/8 (37.5%)
$0.42 (2.26%)
63
Hold
$19
$15
2 years 17 days ago
(26-Sep-2023)
3/13 (23.08%)
$0.42 (2.26%)
57
What Year was the first public recommendation made by Jim Molloy?